Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors
p62 DNA疫苗ELENAGEN在晚期实体瘤患者中的首次人体试验中的安全性和有效性
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.16574
Ponomarenko, Dmitry M; Klimova, Irina D; Chapygina, Yulia A; Dvornichenko, Viktoria V; Zhukova, Natalia V; Orlova, Rashida V; Manikhas, Georgy M; Zyryanov, Alexandr V; Burkhanova, Lilya A; Badrtdinova, Irina I; Oshchepkov, Basile N; Filippova, Elena V; Orlov, Sergei V; Kolesnikov, Sergei I; Sufianov, Albert A; Baum, Svetlana R; Zaitzeva, Olga Y; Komissarov, Andrey B; Grudinin, Mikhail P; Kiselev, Oleg I; Tsyb, Anatoly F; Venanzi, Franco; Shcherbinina, Vita; Chursov, Andrey; Gabai, Vladimir L; Shneider, Alexander M